# BillionToOne, Inc.: filings

BLLN · Nasdaq · CIK 2070849 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/blln.md) · [Financials](/companies/blln/financials.md) · [Filings](/companies/blln/filings.md) · [Insiders](/companies/blln/insiders.md)

## Reports and events: 16 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 66, 144 53, 3 16, 8-K 8, 10-Q 3, SCHEDULE 13G 3, DRS/A 2, DRSLTR 2, UPLOAD 2, 10-K 1, 144/A 1, 424B4 1, 8-A12B 1, ARS 1, CERT 1, DEF 14A 1, DEFA14A 1, DRS 1, S-1 1, S-1/A 1, S-8 1, SCHEDULE 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-05 | 16:42 ET | [10-Q](/filings/0002070849-26-000050.md) | Quarterly report, period 2026-06-30 | 0002070849-26-000050 |
| 2026-08-05 | 16:25 ET | [8-K](/filings/0002070849-26-000048.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0002070849-26-000048 |
| 2026-06-29 | 16:08 ET | [8-K](/filings/0002070849-26-000042.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0002070849-26-000042 |
| 2026-06-16 | 16:57 ET | [8-K](/filings/0002070849-26-000040.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0002070849-26-000040 |
| 2026-05-06 | 16:43 ET | [10-Q](/filings/0002070849-26-000031.md) | Quarterly report, period 2026-03-31 | 0002070849-26-000031 |
| 2026-05-06 | 16:11 ET | [8-K](/filings/0002070849-26-000029.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0002070849-26-000029 |
| 2026-04-21 | 16:25 ET | [DEF 14A](/filings/0002070849-26-000024.md) | Proxy statement, period 2026-06-10 | 0002070849-26-000024 |
| 2026-03-11 | 16:55 ET | [10-K](/filings/0002070849-26-000017.md) | Annual report, period 2025-12-31 | 0002070849-26-000017 |
| 2026-03-04 | 16:07 ET | [8-K](/filings/0002070849-26-000013.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0002070849-26-000013 |
| 2026-01-20 | 19:46 ET | [SCHEDULE 13D](/filings/0001104659-26-005176.md) | Ownership report, active investor | 0001104659-26-005176 |
| 2026-01-12 | 08:09 ET | [8-K](/filings/0002070849-26-000010.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure | 0002070849-26-000010 |
| 2025-12-10 | 16:30 ET | [10-Q](/filings/0001628280-25-056321.md) | Quarterly report, period 2025-09-30 | 0001628280-25-056321 |
| 2025-12-09 | 16:15 ET | [8-K](/filings/0001628280-25-056077.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001628280-25-056077 |
| 2025-11-10 | 16:05 ET | [8-K](/filings/0001193125-25-274195.md) | 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-274195 |
| 2025-10-17 | 17:13 ET | [S-1/A](/filings/0001193125-25-242632.md) | Registration statement, amended | 0001193125-25-242632 |
| 2025-10-07 | 17:30 ET | [S-1](/filings/0001193125-25-233697.md) | Registration statement | 0001193125-25-233697 |

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 18:55 ET. No prices; not investment advice.